Find & Manage Your Patient Assistance Programs
Estimated patient savings $600,000,000.00
Genentech Access To Care Foundation (Rapitiva)


Genentech, Inc. was founded in 1976 by Robert A. Swanson and Dr. Herbert W. Boyer. The company is primarily based around the field of recombinant DNA technology that was founded by Boyer and colleague Stanley Cohen. Over their 30+ year history, Genentech, Inc. has strived to fill the unment needs in the fields of oncology, immunology, and disorders of tissue growth and repair. Genentech, Inc. is considered to be one of the worlds leading biotechnological companies with a portfolio of at least 15 products currently on the market and a development pipeline bursting with well over 100 new ventures.

Genentech, Inc. has provided unparalleled advancements in technology as they where the first biopharmaceutical company in the world to clone human insulin and growth hormone. Genentech, Inc. continues to provide unique and innovate products while guaranteeing their employees have the best environment possible, as is evident by their tenth consecutive year in FORTUNE magazines “100 Best Companies to Work For”.

Raptiva is an immunosuppressant launched by Genentech, Inc. in 2003. Raptiva has been approved by the FDA for treatment of all levels of psoriasis. Raptiva is administered through injection.


Genentech Access to Care Foundation (Raptiva), a patient assistance program provided by Genentech, Inc., offers Raptiva at no cost for up to 1 year to those who are eligible for the program. Eligibility is based off of the following requirements:

- You must be uninsured or underinsured.

- You must meet an undisclosed income guideline.

Those eligible for Medicare Part D but not enrolled may still be eligible.

SOURCE: 2008 Poverty Chart
Family Size
Each Additional Family Member

What´s Next?

Fill out the program enrollment form located to your right. If you don't see an enrollment form available please call Genentech, Inc. program directly. After filling out the enrollment form please bring the form to your doctor for proper signatures and procedures. Do not forget a self stamped envelope for them to mail in your application to the program.

Other Tips

  • If you have any questions please call the Genentech, Inc. program directly.
  • Fill out as much of the information on the enrollment form as possible. The more information you have pre-filled the easier the progrm is to enroll in.
  • Write down the refill dates for your program and set a reminder here on so that you don't run out of medication.
  • Do not write messy on your forms as this will delay any response.
  • Call and write thank you notes to AAI Pharma Inc. program. Without their help millions of people will be without medication.

← Back to Assistance Programs